Decoy Therapeutics Inc. (DCOY) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Decoy Therapeutics Inc. (DCOY) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.5M, listed on NASDAQ, employing roughly 11 people, carrying a beta of 0.58 to the broader market. Based in Cambridge, Massachusetts, Decoy Therapeutics Inc. Led by Frederick E. Pierce, public since 2015-01-29.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for DCOY as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →